LRRK2 Mutation and Parkinson's Disease

Stopped Following extensive efforts to increase recruitment, it will not be possible to complete the study protocol within a reasonable time

Conditions

• Parkinson Disease

Interventions

• GENETIC: Healthy
• GENETIC: PKD Patients

Sponsor

GlaxoSmithKline